NASDAQ:ADRO - Aduro BioTech News Headlines

Sign in or create an account to add this stock to your watchlist.
$3.62 +0.07 (+1.97 %)
(As of 04/26/2019 10:47 AM ET)
Previous Close$3.55
Today's Range$3.51 - $3.6250
52-Week Range$2.34 - $9.00
Volume26,814 shs
Average Volume636,468 shs
Market Capitalization$289.06 million
P/E RatioN/A
Dividend YieldN/A
Beta2.06

Headlines

Aduro BioTech (NASDAQ ADRO) News Headlines

Source:
DateHeadline
$8.08 Million in Sales Expected for Aduro BioTech Inc (ADRO) This Quarter$8.08 Million in Sales Expected for Aduro BioTech Inc (ADRO) This Quarter
www.americanbankingnews.com - April 26 at 4:58 AM
Aduro Biotech (ADRO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Aduro Biotech (ADRO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
finance.yahoo.com - April 24 at 6:25 PM
Zacks: Analysts Anticipate Aduro BioTech Inc (ADRO) to Post -$0.17 EPSZacks: Analysts Anticipate Aduro BioTech Inc (ADRO) to Post -$0.17 EPS
www.americanbankingnews.com - April 24 at 2:18 AM
Aduro Biotech Appoints Dimitry S.A. Nuyten, M.D., Ph.D. as Chief Medical OfficerAduro Biotech Appoints Dimitry S.A. Nuyten, M.D., Ph.D. as Chief Medical Officer
finance.yahoo.com - April 22 at 8:27 AM
Aduro Biotech Abstracts Accepted for Presentation at the 2019 American Society of Clinical Oncology Annual MeetingAduro Biotech Abstracts Accepted for Presentation at the 2019 American Society of Clinical Oncology Annual Meeting
finance.yahoo.com - April 17 at 7:13 PM
Aduro BioTech Inc to Post Q1 2019 Earnings of ($0.03) Per Share, Svb Leerink Forecasts (ADRO)Aduro BioTech Inc to Post Q1 2019 Earnings of ($0.03) Per Share, Svb Leerink Forecasts (ADRO)
www.americanbankingnews.com - April 17 at 7:45 AM
Svb Leerink Comments on Aduro BioTech Incs Q2 2019 Earnings (ADRO)Svb Leerink Comments on Aduro BioTech Inc's Q2 2019 Earnings (ADRO)
www.americanbankingnews.com - April 16 at 6:41 AM
Aduro BioTech (ADRO) Now Covered by Svb LeerinkAduro BioTech (ADRO) Now Covered by Svb Leerink
www.americanbankingnews.com - April 15 at 11:13 AM
Leerink Swann Begins Coverage on Aduro BioTech (ADRO)Leerink Swann Begins Coverage on Aduro BioTech (ADRO)
www.americanbankingnews.com - April 15 at 9:11 AM
Insider Selling: Aduro BioTech Inc (ADRO) CFO Sells 18,601 Shares of StockInsider Selling: Aduro BioTech Inc (ADRO) CFO Sells 18,601 Shares of Stock
www.americanbankingnews.com - April 10 at 8:38 PM
Financial Contrast: Depomed (DEPO) and Aduro BioTech (ADRO)Financial Contrast: Depomed (DEPO) and Aduro BioTech (ADRO)
www.americanbankingnews.com - April 10 at 2:20 AM
What Kind Of Shareholders Own Aduro BioTech, Inc. (NASDAQ:ADRO)?What Kind Of Shareholders Own Aduro BioTech, Inc. (NASDAQ:ADRO)?
finance.yahoo.com - April 8 at 7:37 PM
Aduro BioTech Inc (ADRO) Given Average Recommendation of "Hold" by BrokeragesAduro BioTech Inc (ADRO) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 3 at 9:50 AM
Aduro BioTech Inc (ADRO) Expected to Announce Quarterly Sales of $4.77 MillionAduro BioTech Inc (ADRO) Expected to Announce Quarterly Sales of $4.77 Million
www.americanbankingnews.com - April 3 at 3:50 AM
Aduro Biotech to Present at the H.C. Wainwright Global Life Sciences ConferenceAduro Biotech to Present at the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - April 1 at 8:44 AM
Zacks: Brokerages Anticipate Aduro BioTech Inc (ADRO) to Announce -$0.19 Earnings Per ShareZacks: Brokerages Anticipate Aduro BioTech Inc (ADRO) to Announce -$0.19 Earnings Per Share
www.americanbankingnews.com - April 1 at 8:38 AM
Why Is Aduro Biotech (ADRO) Down 10.7% Since Last Earnings Report?Why Is Aduro Biotech (ADRO) Down 10.7% Since Last Earnings Report?
www.nasdaq.com - March 30 at 8:34 AM
Aduro Biotech to Present at Two Upcoming Investor Conferences in MarchAduro Biotech to Present at Two Upcoming Investor Conferences in March
finance.yahoo.com - March 7 at 8:50 AM
What Should We Expect From Aduro BioTech, Inc.’s (NASDAQ:ADRO) Earnings In The Years Ahead?What Should We Expect From Aduro BioTech, Inc.’s (NASDAQ:ADRO) Earnings In The Years Ahead?
finance.yahoo.com - March 2 at 8:25 AM
Aduro Biotech Announces Upcoming Presentations at AACR Annual Meeting 2019Aduro Biotech Announces Upcoming Presentations at AACR Annual Meeting 2019
finance.yahoo.com - February 28 at 8:42 AM
Top Ranked Momentum Stocks to Buy for February 27thTop Ranked Momentum Stocks to Buy for February 27th
finance.yahoo.com - February 27 at 7:08 PM
Aduro Biotech Reports Fourth Quarter and Full Year 2018 Financial ResultsAduro Biotech Reports Fourth Quarter and Full Year 2018 Financial Results
finance.yahoo.com - February 27 at 7:08 PM
Aduro Announces Changes to its Board of DirectorsAduro Announces Changes to its Board of Directors
finance.yahoo.com - February 21 at 8:53 AM
Aduro Biotech to Present at the 8th Annual SVB Leerink Global Healthcare ConferenceAduro Biotech to Present at the 8th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 21 at 8:53 AM
Aduro Biotech (ADRO) Reports First Patient Dosed in Phase 1 Study of ADU-S100 (MIW815) in Combination with YERVOY (ipilimumab) for Treatment of Relapsed & Refractory Melanoma - StreetInsider.comAduro Biotech (ADRO) Reports First Patient Dosed in Phase 1 Study of ADU-S100 (MIW815) in Combination with YERVOY (ipilimumab) for Treatment of Relapsed & Refractory Melanoma - StreetInsider.com
www.streetinsider.com - February 12 at 6:29 PM
Aduro Announces First Patient Dosed in Phase 1 Study of ADU-S100 (MIW815) in Combination with YERVOY (ipilimumab) for the Treatment of Relapsed and Refractory MelanomaAduro Announces First Patient Dosed in Phase 1 Study of ADU-S100 (MIW815) in Combination with YERVOY (ipilimumab) for the Treatment of Relapsed and Refractory Melanoma
finance.yahoo.com - February 11 at 9:21 AM
Top Ranked Momentum Stocks to Buy for February 6th - NasdaqTop Ranked Momentum Stocks to Buy for February 6th - Nasdaq
www.nasdaq.com - February 8 at 8:33 AM
Will Aduro Biotech Continue to Surge Higher?Will Aduro Biotech Continue to Surge Higher?
finance.yahoo.com - February 7 at 8:35 AM
Aduro cuts 37% of workforce in strategic resetAduro cuts 37% of workforce in strategic reset
seekingalpha.com - January 30 at 6:49 PM
Aduro Biotech Announces Strategic ResetAduro Biotech Announces Strategic Reset
finance.yahoo.com - January 30 at 8:30 AM
Is Aduro BioTech, Inc. (NASDAQ:ADRO) A Volatile Stock?Is Aduro BioTech, Inc. (NASDAQ:ADRO) A Volatile Stock?
finance.yahoo.com - January 25 at 5:59 PM
Aduro Biotech (ADRO) Upgraded to Strong Buy: What Does It Mean for the Stock?Aduro Biotech (ADRO) Upgraded to Strong Buy: What Does It Mean for the Stock?
www.zacks.com - January 21 at 9:38 AM
Aduro Biotech (ADRO) Presents At 37th Annual J.P. Morgan Healthcare Conference - SlideshowAduro Biotech (ADRO) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 11 at 6:27 PM
Form SC 13G/A ADURO BIOTECH, INC. Filed by: SINGER JAMES R - StreetInsider.comForm SC 13G/A ADURO BIOTECH, INC. Filed by: SINGER JAMES R - StreetInsider.com
www.streetinsider.com - January 8 at 8:37 AM
Aduro BioTech (ADRO) Looks Good: Stock Adds 7.7% in SessionAduro BioTech (ADRO) Looks Good: Stock Adds 7.7% in Session
www.zacks.com - January 4 at 9:25 AM
Aduro Biotech to Present at the 37th Annual J.P. Morgan Healthcare ConferenceAduro Biotech to Present at the 37th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 3 at 8:44 AM
What You Must Know About Aduro BioTech, Inc.’s (NASDAQ:ADRO) Financial StrengthWhat You Must Know About Aduro BioTech, Inc.’s (NASDAQ:ADRO) Financial Strength
finance.yahoo.com - December 20 at 5:27 PM
ADIL On The Job, ADRO Teams Up With LLY, So Long CIVIADIL On The Job, ADRO Teams Up With LLY, So Long CIVI
www.nasdaq.com - December 20 at 8:35 AM
Todays Research Reports on Trending Tickers: Aduro BioTech and Adial PharmaceuticalsToday's Research Reports on Trending Tickers: Aduro BioTech and Adial Pharmaceuticals
finance.yahoo.com - December 20 at 8:35 AM
Aduro Biotech Inc.Aduro Biotech Inc.
www.barrons.com - December 19 at 5:37 PM
Aduro Biotech, Inc. (ADRO) Pre-Market TradingAduro Biotech, Inc. (ADRO) Pre-Market Trading
www.nasdaq.com - December 19 at 5:37 PM
Biotech Stock Roundup: Pipeline Updates From VRTX & AMGN, ADRO Teams Up With LLYBiotech Stock Roundup: Pipeline Updates From VRTX & AMGN, ADRO Teams Up With LLY
www.zacks.com - December 19 at 8:37 AM
Todays Research Reports on Trending Tickers: Nektar Therapeutics and Aduro BioTechToday's Research Reports on Trending Tickers: Nektar Therapeutics and Aduro BioTech
finance.yahoo.com - December 19 at 8:37 AM
Preclinical data show dosing sensitivity of Aduros STING candidatePreclinical data show dosing sensitivity of Aduro's STING candidate
seekingalpha.com - December 12 at 4:07 PM
Aduro Biotech Data Published in Cell Reports Highlights the Significant Role of the Magnitude of Intratumoral STING Activation by ADU-S100 in Anti-Tumor ImmunityAduro Biotech Data Published in Cell Reports Highlights the Significant Role of the Magnitude of Intratumoral STING Activation by ADU-S100 in Anti-Tumor Immunity
finance.yahoo.com - December 12 at 8:35 AM
Aduro Biotech Enters Oversold TerritoryAduro Biotech Enters Oversold Territory
finance.yahoo.com - December 5 at 8:31 AM
Aduro Biotech and Dana-Farber Cancer Institute Present Preclinical Data Supporting Anti-APRIL Antibody BION-1301 for the Treatment of Multiple Myeloma at the 60th American Society of Hematology Annual Meeting and Exposition - GlobeNewswireAduro Biotech and Dana-Farber Cancer Institute Present Preclinical Data Supporting Anti-APRIL Antibody BION-1301 for the Treatment of Multiple Myeloma at the 60th American Society of Hematology Annual Meeting and Exposition - GlobeNewswire
globenewswire.com - December 4 at 5:29 PM
Aduro Biotech (ADRO), Dana-Farber Cancer Institute Present Preclinical Data Supporting Anti-APRIL Antibody BION-1301 for Treatment of MM at ASHAduro Biotech (ADRO), Dana-Farber Cancer Institute Present Preclinical Data Supporting Anti-APRIL Antibody BION-1301 for Treatment of MM at ASH
www.streetinsider.com - December 3 at 5:06 PM
Aduro Biotech and Dana-Farber Cancer Institute Present Preclinical Data Supporting Anti-APRIL Antibody BION-1301 for the Treatment of Multiple Myeloma at the 60th American Society of Hematology Annual Meeting and ExpositionAduro Biotech and Dana-Farber Cancer Institute Present Preclinical Data Supporting Anti-APRIL Antibody BION-1301 for the Treatment of Multiple Myeloma at the 60th American Society of Hematology Annual Meeting and Exposition
finance.yahoo.com - December 3 at 8:36 AM
Why Is Aduro Biotech (ADRO) Down 40.1% Since Last Earnings Report?Why Is Aduro Biotech (ADRO) Down 40.1% Since Last Earnings Report?
www.zacks.com - November 30 at 8:56 AM
This page was last updated on 4/26/2019 by MarketBeat.com Staff

Featured Article: What is a recession?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel